(1R,2S,3R,4R,4aS,8aR)-1-(Benzoyloxy)-3-hydroxy-3,4,8,8a-tetramethyl-4-[(E)-2-(5-oxo-2,5-dihydro-3-furanyl)vinyl]-1,2,3,4,4a,5,6,8a-octahydro-2-naphthalenyl nicotinate(CAS: 1312716-27-0)

The compound is a crystalline solid with a molecular weight of approximately 662.68 g/mol. It has a low water solubility and moderate solubility in organic solvents like ethanol and dichloromethane. The compound is relatively stable but may react with strong bases, acids, and reducing agents. It shows good reactivity towards nucleophiles and electrophiles.

The synthesis involves condensation of nicotinic acid with a specific furan derivative under anhydrous conditions, followed by benzoylation and ring expansion. The reaction is catalyzed by a palladium-based catalyst and proceeds with high selectivity and yield. Detailed procedures can be found in organic synthesis literature.

This compound is primarily used in the pharmaceutical industry for its potential in developing new drugs due to its structural complexity and bioactivity. It may also find applications in the polymer and sensor industries for its unique chemical properties.

Proper personal protective equipment (PPE) should be worn, including gloves, goggles, and a laboratory coat. Store the compound in a cool, dry place away from strong acids and bases. Use a fume hood during handling. In case of spillage, use appropriate spill cleanup procedures and consult the Safety Data Sheet (SDS) for detailed instructions.